azane;(1S,4S,5R,8S,9R,12S,13R)-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecan-10-one

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 异戊烯醇脂质
• 英文名称: azane;(1S,4S,5R,8S,9R,12S,13R)-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecan-10-one
• 化学式: C15H25NO5
• 分子量: 299.36
• InChiKey: QGRIIAHNAAOAAV-YXBLWPJUSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.56
• 重原子数：
  21
• 可旋转键数：
  0
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.93
• 拓扑面积：
  55
• 氢给体数：
  1
• 氢受体数：
  6

文献信息

• ARTEMISININ COMPOUNDS AND SYNTHESIS AND USE THEREOF
  申请人：UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION

  公开号：US20150344493A1

  公开（公告）日：2015-12-03

  The present disclosure describes artemisinin compounds. The compounds can be synthesized using an Ugi synthesis reaction and can be used in the treatment of cancers, parasitic infections and yeast infections.
• US9422306B2
  申请人：——

  公开号：US9422306B2

  公开（公告）日：2016-08-23
• [EN] ARTEMISININ COMPOUNDS AND SYNTHESIS AND USE THEREOF<br/>[FR] COMPOSÉS D'ARTÉMISINE ET LEUR SYNTHÈSE ET LEUR UTILISATION
  申请人：UNIV WASHINGTON CT COMMERCIALI

  公开号：WO2014100486A1

  公开（公告）日：2014-06-26

  The present disclosure describes artemisinin compounds. The compounds can be synthesized using an Ugi synthesis reaction and can be used in the treatment of cancers, parasitic infections and yeast infections.